Assisted Reproductive Technology Does Not Raise Risk of Ovarian Cancer, Study Indicates

Assisted Reproductive Technology Does Not Raise Risk of Ovarian Cancer, Study Indicates
Women who use assisted reproductive technology to help them conceive a child appear not to be at an increased risk of developing ovarian cancer, a nationwide study conducted in the Netherlands has found. The study, “Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology,” was published in the Journal of the National Cancer Institute. Since the implementation of assisted reproductive technology (ART) 40 years ago, there have been concerns that these methods may raise a woman’s risk of developing ovarian cancer later in life. This is because these strategies, which include in vitro fertilization, intracytoplasmic sperm injection, and embryo cryopreservation, use hormones to stimulate ovulation, which may also lead to the formation of tumors due to excessive ovary stimulation. Additionally, there is also the concern that the repeated ovary punctures required during these procedures may disrupt ovary tissues and also promote tumor formation. “Because of the worldwide increase in the use of ART and the poor prognosis of ovarian cancer, it is important from a public health perspective to examine the association between ART and long-term ovarian tumor incidence,” the researchers wrote. Although several studies have attempted to shed light on the possible relationship between ART and ovarian cancer risk, their findings have been inconsistent. In 2013, two meta-analyses reported that women resorting to ART to conceive were 35–50% more likely to develop ovarian cancer than those in the general population. However, it was still unclear if this increased ovarian cancer risk was a direct consequence of fertility treatments, or if it could be associated with other factors, such as infertility itself. Conducted
Subscribe or to access all post and page content.